VSTM – verastem, inc. (US:NASDAQ)

News

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference
Verastem (NASDAQ:VSTM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
Verastem Oncology to Present at Upcoming Investor Conferences
Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com